Revvity

Revvity, founded in 2023, is an innovative health science company headquartered in the United States. With the slogan, "Expanding the boundaries of human potential through science," Revvity is committed to transforming healthcare through cutting-edge solutions and technologies. This burgeoning company specializes in providing comprehensive workflows for healthcare challenges, covering stages from discovery and development to diagnosis and cure.

Revvity operates in several key areas, including translational multi-omics technologies, biomarker identification, and diagnostics, serving a broad client base across pharmaceutical industries, biotech, diagnostics labs, academia, and governments. Its impressive performance is reflected in its revenues exceeding $3 billion and a workforce of over 11,000 employees. As part of the S&P 500 index and with a global reach across more than 190 countries, Revvity presents a valuable opportunity for investors seeking innovation-driven growth in the healthcare sector.